Tackling the epidemic of chronic noncommunicable disease in sub Saharan Africa: established priorities and new concerns
|
|
- Alaina Alexander
- 6 years ago
- Views:
Transcription
1 Tackling the epidemic of chronic noncommunicable disease in sub Saharan Africa: established priorities and new concerns Nigel Unwin Institute of Health and Society Newcastle University
2 Overview and acknowledgements Investigations into burden and health care coverage Some implications for research New concerns links between infectious and NCDs Cameroon JC Mbanya E Sobngwi A Paschal Tanzania D McLarty F Mugusi H Kitange S Rashid UK George Alberti Philip Setel David Whiting
3 Adult Morbidity and Mortality Project (AMMP) Annual or biannual censuses, key informant system to identify deaths and verbal autopsy with next of kin
4 Deaths from NCDs in women (15-59 years), in 3 areas of Tanzania and EMEs Percentage of all deaths Rate % 10 Dar Moro Rural Hai EMEs 0
5 Deaths from NCDs in women (15-59 years), in 3 areas of Tanzania and EMEs. Death rates Percentage of all deaths Rate % 0 Dar Moro Rural Hai EMEs 0 Data for year 2000
6 Age-specific death rates from stroke in England and Wales Log rate per 100, M E&W W E&W Age
7 Age-specific death rates from stroke in England and Wales and Dar es Salaam Log rate per 100, M Dar M E&W W Dar W E&W Age
8 Prevalence (%) of Diabetes - fbg > 6.1 mmol/l Women Men Dar Hai 8 6 Dar Hai Age group
9 Prevalence (%) of BMI > 25 Women Men Dar Hai Dar Hai Age group
10 Care for Diabetes in Dar es Salaam 80% to 90% undiagnosed In a pop based survey of 170 diagnosed: 28% of diagnosed claim to attend clinic reg. Health services provide care for ~3% of all DM But 20% of these missed most recent appt. 50% to 60% had not tested blood glucose in previous month 3% of those diagnosed were well-controlled (HBA1c < 7%)
11
12 Key research themes Surveillance Addressing the need for better data Treatment Improving the effectiveness and efficiency and currently expended resources Prevention Approaches appropriate to the social, cultural and economic conditions (Medical logic => social logic)
13
14 DCPDC Cost saving diabetes interventions HBA1c control < 9% BP control < 160/95 Foot care examination and education
15 New concerns Co-morbidity between infectious and chronic non-communicable diseases Potential public health importance Awareness raising on impact of NCDs Diabetes and TB HIV treatment and diabetes/cvd risk
16 TB and Diabetes In the past, a relationship between TB and diabetes was recognised (TB-DM clinics in 1950s UK) Little recognition of relationship in current policy guidance May have implications for management e.g. case finding and diabetes treatment among TB patients
17 Possible mechanisms Diabetes increases risk TB infection Diabetes causes progression from latent to active disease Reverse causality TB may worsen glycaemic control (some medications have hyperglycaemic effects)
18 Review of TB-DM studies Literature review of studies assessing TB DM association, studies (1995-Jan 2007) 1 prospective cohort, 6 case-control (3 based on routine data), 2 further analyses using routine data sources Geographical location 2 from US, and 1 each from the UK, Mexico, Russia, Korea, Indonesia, India, Canada Stevenson et al. Chronic Illness Vol. 3 No. 3, (2007)
19 Results of review Adjusted ORs or RR
20 Pulmonary TB and diabetes in India attributable risk estimates Data sources: TB incidence from WHO estimates based on notifications from the Revised National TB Control Programme for India Prevalence of diabetes from Prevalence of Diabetes in India Study (PODIS) involving >18,000 adults in rural and urban areas Age specific relative risk from study of >80,000 Korean civil servants (Kim et al. 1995) Source: Stephenson et al BMC Public Health 2007, 7:34
21 Pulmonary TB and diabetes in India attributable risk estimates (2) TB incidence attributable to diabetes in adults (25 years +): 15% of all pulmonary TB 20% smear positive TB Over a 5 th of excess in urban areas Diabetes in people with TB 18% of all cases of pulmonary TB have diabetes 24% of those with smear positive TB have diabetes Source: Stephenson et al BMC Public Health 2007, 7:34
22 Impact of diabetes in TB Increased mortality Longer to sputum negativity Increased relapsed Stevenson et al. Chronic Illness Vol. 3 No. 3, (2007)
23 Implications of DM-TB for Africa TB 363/100,000 per year 2.8 million new cases per year 4.2 million prevalent cases 22% HIV positive Diabetes Low prevalence in rural areas (1%) High and rising prevalence in urban areas (5-10%)
24 TB-DM Research needs in Africa Strength of the association Prevalence of DM and pre diabetes in TB Impact of DM and pre diabetes on TB outcomes
25 HIV, antiretroviral therapy and risk of Diabetes and Cardiovascular Disease
26 Influence of HIV related factors on metabolic risk Triglycerides with some ARTs e.g. efavirenz/stavudine Insulin resistance with some ARTs e.g. NRTIs Lipoatrophy NRTIs (esp stavudine), NNRTIs, PIs Diabetes with PIs,? others
27 Impact of ARTs on metabolic risk in Africa Virtually no published data Recent study from Cameroon Sobngwi/Johnstone/Unwin
28 Study participants by length of time on treatment Group allocation based on months on treatment P ro p o rti o n Group Frequency Percentage
29 Mean waist-hip by treatment group Mean waist-hip <12 <24 <36 <48 <60 mean Relationship independent of age, sex and BMI
30 ART need and coverage in Africa in 2005, research needs Need: 4.7 million Coverage: 310,000 (17%) Research Define metabolic consequences? need for preventive interventions
31 In summary Place of NCDs on overall disease burden Research agenda, based largely implementing knowledge on treatment and prevention into an African setting Links between NCDs and infectious disease New research needs
32 Thank you
DM and TB Double Burden. Anil Kapur
DM and TB Double Burden Anil Kapur Association Between TB and DM Global Burden of DM and TB Diabetes Mellitus: 2011 Tuberculosis: 2011 [IDF Atlas 5 th Edition 2011] [WHO- Global TB Control 2012] 366 M
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More information7.5 South-East Asian Region: summary of planned activities, impact and costs
PART II: GLOBAL AND REGIONAL SCENARIOS FOR TB CONTROL 26 215 7.5 South-East Asian Region: summary of planned activities, impact and costs Achievements DOTS expanded rapidly in the South-East Asian Region
More informationSocio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania
Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Dr. Fausta Franklin Mosha (MD, MSc, MSc, PHD) Ministry of Health and Social Welfare 22 nd October
More informationINTEGRATION OF PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES AND TUBERCULOSIS: A CASE FOR ACTION
INTEGRATION OF PREVENTION AND CONTROL OF NONCOMMUNICABLE DISEASES AND TUBERCULOSIS: A CASE FOR ACTION Global commitments to prevent and control noncommunicable diseases and to end the global tuberculosis
More informationEthiopia. Integrating Service Delivery for TB and Diabetes Mellitus An Innovative and Scalable Approach in Ethiopia PROJECT CONTEXT
Technical BRIEF Photo Credit: Dai Tran Integrating Service Delivery for TB and Diabetes Mellitus An Innovative and Scalable Approach in Ethiopia PROJECT CONTEXT The burden of non-communicable diseases
More informationA Review on Prevalence of TB and HIV Co-infection
Human Journals Review Article May 2015 Vol.:1, Issue:1 All rights are reserved by Jyoti P. Waghmode et al. A Review on Prevalence of TB and HIV Co-infection Keywords: tuberculosis, HIV, co-infection, prevalence
More informationTUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE CONTROL OF A DUAL EPIDEMIC IN THE WHO AFRICAN REGION. Report of the Regional Director.
30 August 2007 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-seventh session Brazzaville, Republic of Congo, 27 31 August Provisional agenda item 7.8 TUBERCULOSIS AND HIV/AIDS: A STRATEGY FOR THE
More informationGuidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
More informationWorld Health Organization HIV/TB Facts 2011
World Health Organization HIV/TB Facts 20 Note: The facts and figures of the HIV/TB Facts 20 are drawn from WHO HIV and TB surveillance data from 200 and 2009, as referenced below. Why is tuberculosis
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationGBD2013 Tuberculosis estimates of mortality, incidence and prevalence
GBD2013 Tuberculosis estimates of mortality, incidence and prevalence Theo Vos Professor of Global Health March 31, 2015 Tuberculosis estimation strategy 1) Goal: Use all available data on different outcomes
More informationPaediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme [2].tiff
Paediatric HIV Drug Resistance 26th-International-Workshop-on-HIV-Drug-Resistance-programme- 20171031[2].tiff Mo Archary King Edward VIII Hospital / UKZN Paediatric Infectious Diseases Unit Overview State
More informationPROJECT Ntshembo: Improving adolescent health and interrupting mother-infant transfer of health risk in Africa. INDEPTH Network
PROJECT Ntshembo: Improving adolescent health and interrupting mother-infant transfer of health risk in Africa INDEPTH Network Overview Transitions across countries Transitions within countries - South
More informationProgress in scaling up HIV prevention and treatment in sub-saharan Africa: 15 years, the state of AIDS
10 th International Workshop on HIV treatment, Pathogenesis and Prevention Research in Resource-Limited setting (INTEREST, 3-6 May, 2016) Progress in scaling up HIV prevention and treatment in sub-saharan
More informationEstimating TB burden. Philippe Glaziou World Health Organization Accra, Ghana
Estimating TB burden Philippe Glaziou World Health Organization Accra, Ghana Outline Basic facts about TB epidemiology What should we expect with regards TB burden over time? Main indicators of TB disease
More informationTB Intensive San Antonio, Texas May 7-10, 2013
TB Intensive San Antonio, Texas May 7-10, 2013 TB and Diabetes Barbara Seaworth, MD May 09, 2013 Barbara Seaworth, MD has the following disclosures to make: No conflict of interests No relevant financial
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB and Diabetes Barbara Seaworth, MD July 19, 2012 Barbara Seaworth, MD, FIDSA, FACP has the following disclosures to make: Has an advisory
More informationCOSTS OF DIABETES IN DEVELOPING COUNTRIES
COSTS OF DIABETES IN DEVELOPING COUNTRIES Jonathan Betz Brown, MPP, PhD Chair, International Diabetes Federation Task Force on Diabetes Health Economics Senior Investigator, Kaiser Permanente Center for
More informationNutrition, Tuberculosis (and HIV) Andrew Thorne-Lyman, ScD MHS
Nutrition, Tuberculosis (and HIV) Andrew Thorne-Lyman, ScD MHS 1 Preview Overview of the epidemics How nutritional status influences TB transmission and treatment outcomes WHO Nutritional care and support
More informationThe growing burden of noncommunicable diseases (NCDs)
The WHO Noncommunicable Diseases Global Surveillance Strategy: Experience in the African Region Burden of noncommunicable diseases The growing burden of noncommunicable diseases (NCDs) represents a major
More informationThe epidemiology of tuberculosis
The epidemiology of tuberculosis Tuberculosis Workshop Shanghai, 12-22 May 28 Philippe Glaziou World Health Organization Outline Epidemiology refresher Estimates of tuberculosis disease burden Notifications
More informationThe population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort
The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Findings from the Africa Centre s population cohort Frank Tanser Presentation at the South African Clinicians Society Conference
More informationAt the change of government, South Africa faced important health challenges. The country was bearing
Health Challenges Past and Future Cally Ardington and Anne Case Chapter 41 in The Oxford Companion to the Economics of South Africa, Haroon Bhorat, Alan Hirsch, Ravi Kanbur and Mthuli Ncube (eds.), Oxford
More informationGLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY
GLOBAL TUBERCULOSIS REPORT EXECUTIVE SUMMARY 2018 Context On 26 September 2018, the United Nations (UN) will hold its first highlevel meeting on tuberculosis (TB), at its headquarters in New York. The
More informationHealth outcomes & research objectives in (crosscultural)international
Health outcomes & research objectives in (crosscultural)international research Brian Oldenburg Professor of International Public Health & Associate Dean (Global Health and International Campuses) brian.oldenburg@monash.edu
More informationWHO Health Statistics : Applied through the lens of the Global Monitoring Framework for the Prevention and Control of Noncommunicable Diseases
WHO Health Statistics : Applied through the lens of the Global Monitoring Framework for the Prevention and Control of Noncommunicable Diseases Dr E Tursan d'espaignet Prevention of Noncommunicable Diseases
More informationInvesting for Impact
Global Fund Strategic Framework: Investing for Impact M&E: Capturing data to improve services Workshop to Scale Up the Implementation of Collaborative TB/HIV Activities in Africa 10-11 April, 2013; Maputo,
More informationTechnical Review Meeting of Country Experiences in ARV Toxicity Surveillance: Sharing Results and Lessons Learnt, Identifying Solutions
Technical Review Meeting of Country Experiences in ARV Toxicity Surveillance: Sharing Results and Lessons Learnt, Identifying Solutions 7-8 November 2013, Geneva Excellent healthcare locally delivered
More informationWhy Non communicable Diseases? Why now?
Why Non communicable Diseases? Why now? Professor Michelle A. Williams Chair, Department of Epidemiology Harvard School of Public Health November 8, 2012 Addis Ababa, Ethiopia Non communicable Diseases
More informationImproving accessibility to antiretroviral drugs: A south-south collaboration
Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000
More informationTest & Treat : Changing the face of insurance for persons living with HIV?
Test & Treat : Changing the face of insurance for persons living with HIV? Kadene Gibbs FSA, MSc Dr Matthew Procter Agenda 1. Background 2. Understanding HIV and Factors affecting Prognosis 3. History
More informationAntiretroviral treatment outcomes after the introduction of tenofovir in the public-sector in South Africa
Antiretroviral treatment outcomes after the introduction of tenofovir in the public-sector in South Africa Alana T Brennan, Kate Shearer, Mhairi Maskew, Prudence Ive, Ian Sanne, Matthew P Fox Health Economics
More informationQuestions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs
Questions and Answers Press conference - Press Centre Room 3 Wednesday 16 August 2006, 14.00hrs What causes TB? TB is caused by the bacterium Mycobacterium tuberculosis. Although it can cause disease in
More informationTB epidemic and progress towards the Millennium Development Goals
Open Forum 4: Key issues in TB Drug Development, August 18, 2010, Addis Ababa, Ethiopia TB epidemic and progress towards the Millennium Development Goals Haileyesus Getahun Stop TB Department, WHO Geneva,
More informationMathematical modelling approach to estimating TB burden in children Pete Dodd (University of Sheffield) & James Seddon (Imperial College London)
Mathematical modelling approach to estimating TB burden in children Pete Dodd (University of Sheffield) & (Imperial College London) Wednesday, 1 April 215 Health Economics & Decision Science School of
More informationTB in the SEA Region. Review Plans and Progress. Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO
TB in the SEA Region Review Plans and Progress Dr Md Khurshid Alam Hyder Medical Officer TB SEARO/WHO The SEA Region: 25% of the world s people, but >33% of TB patients Eastern M editerranean Region 5%
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationWhat we need to know: The role of HIV surveillance in ending the AIDS epidemic as a public health threat
3 rd Global HIV/AIDS Surveillance Meeting What we need to know: The role of HIV surveillance in ending the AIDS epidemic as a public health threat Peter D Ghys (UNAIDS) Daniel Low-Beer (WHO) Irum Zaidi
More informationThe population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort
The population impacts of ART scale-up in rural KwaZulu-Natal, South Africa: Results from the Africa Centre s population cohort Frank Tanser Presentation at 8 th International Workshop on HIV Treatment,
More informationIn 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.
F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected
More informationRecipients of development assistance for health
Chapter 2 Recipients of development assistance for health Both low- and middle-income countries are eligible for development assistance for health (DAH). In addition to income, burden of disease, which
More informationMeasuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT
Measuring progress in global tuberculosis control: WHO Policy and Recommendations DRAFT IMPORTANT NOTE: The main policies and recommendations are summarized on page 6 (synthesis of recommendations for
More informationAntiretroviral Pharmacovigilance Training Course. Dar es Salaam, United Republic of Tanzania
Antiretroviral Pharmacovigilance Training Course Dar es Salaam, United Republic of Tanzania 23 rd 28 th November 2009 SAFETY MONITORING OF ARVs IN GHANA NATIONAL AIDS/STI CONTROL PROGRAMME FOOD AND DRUGS
More informationBurden and measurement of Noncommunicable diseases
Burden and measurement of Noncommunicable diseases Hai-Rim Shin MD., Ph.D. NCD and Health Promotion Team (NHP) WPRO, WHO Burden of Disease Incidence, Mortality, Morbidity (Prevalence): by site, age group,
More informationSubstance Abuse and Tuberculosis Springfield, IL April 27, 2011
Substance Abuse and Tuberculosis Springfield, IL April 27, 2011 Co-morbidities in Substance Abuse that Impact Managing TB Lisa Armitige, MD, PhD April 27, 2011 Lisa Armitige, MD, PhD has the following
More informationNon communicable Diseases
Non communicable Diseases Vision, Goals and Challenges Where we are in Palestine? Dr. Johny R. Khoury Consultant Cardiologist Medical Relief Prevention and Diagnostic Center of cardiovascular diseases
More informationNational Health & Morbidity Survey 2015; NCD Risk Factors
Ministry of Health Malaysia National Health & Morbidity Survey 2015; NCD Risk Factors ZALMA ABDUL RAZAK Nutrition Division Ministry of Health Malaysia 2 Introduction The National Health and Morbidity Survey
More informationKenya Perspectives. Post-2015 Development Agenda. Tuberculosis
Kenya Perspectives Post-2015 Development Agenda Tuberculosis SPEAKERS Anna Vassall Anna Vassall is Senior Lecturer in Health Economics at the London School of Hygiene and Tropical Medicine. She is a health
More informationThe Dual Threat of Diabetes and Tuberculosis in the Americas
The Dual Threat of Diabetes and Tuberculosis in the Americas Table of Contents Abstract...2 Introduction...3 Method...4 Results...6 Incidence of Tuberculosis... 8 Prevalence of Diabetes... 9 Incidence
More informationEPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN
EPIDEMIOLOGY OF TUBERCULOSIS AND the IMPACT ON CHILDREN Anneke C. Hesseling Professor in Paediatrics and Child Health Director: Desmond Tutu TB center Stellenbosch University 11 September 11 th International
More informationChildhood Tuberculosis in the Kilimanjaro region: lessons from the TB Program
Childhood Tuberculosis in the Kilimanjaro region: lessons from the TB Program Charles M. Mtabho Gibson S. Kibiki Constantine F. Irongo Martin J. Boeree Rob E. Aarnoutse Introduction Tuberculosis (TB) remains
More informationResponse to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria.
Response to Treatment in Sputum Smear Positive Pulmonary Tuberculosis Patients In relation to Human Immunodeficiency Virus in Kano, Nigeria. Yusuf Mohammed, Mukhtar Dauda, Ifeanyi Oyeyi TB/HIV Unit, International
More informationMapping RHD in Tanzania July 2015 March Dr Delilah Kimambo M.D. Cardiologist
Mapping RHD in Tanzania July 2015 March 2016 Dr Delilah Kimambo M.D. Cardiologist INTRODUCTION Rheumatic heart disease (RHD) represents an interesting intersection of NCDs, infectious disease, and child
More informationChange In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi:
Change In Population TB Incidence Trends After The Roll-Out Of ART in Karonga District, North Malawi: 1986-2009 Rein Houben/Sebastian Mboma Karonga Prevention Study Incidence of SS+ TB (n/100,000/year
More informationCurrent situation and capacity in the South-East Asia Region
Current situation and capacity in the South-East Asia Region Theme: Diabetes / Obesity Chandrika N Wijeyaratne Sri Lanka Medical Association TWG on Regional Action Plan on NCD Bangkok June 2013 INDICATORS
More informationEndocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort
Endocrinopathy and Leukocyte Telomere Length in HIV+ Individuals in the CARMA Cohort Kristen M. Sokalski, Alice Mai, Jackson Chu, Hélène Côté, Evelyn J. Maan, Arianne Albert, Neora Pick, Deborah Money,
More informationWHO Africa Region Cervical Cancer Control Policies and Strategies
WHO Africa Region Cervical Cancer Control Policies and Strategies Dr. JM. DANGOU WHO-AFRO 1 Regional Conference on New Opportunities and Innovations in Cervical Cancer Prevention The second cause of cancer
More informationWASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON
WASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON SCOTT LINDQUIST MD MPH WASHINGTON STATE DEPARTMENT OF HEALTH STATE EPIDEMIOLOGIST FOR COMMUNICABLE DISEASES FOREIGN-BORN
More informationThe Struggle with Infectious Disease. Lecture 6
The Struggle with Infectious Disease Lecture 6 HIV/AIDS It is generally believed that: Human Immunodeficiency Virus --------- causes ------------- Acquired Immunodeficiency Syndrome History of HIV HIV
More informationOPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health
OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents Health Every Woman Every Child 2016 OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents
More informationAntiretroviral therapy for adults and adolescents KEY MESSAGES. HIV/AIDS Department BACKGROUND
KEY MESSAGES New WHO Recommendations: Antiretroviral therapy for adults and adolescents The World Health Organization (WHO) is revising its guidelines on antiretroviral therapy (ART) for adults and adolescents.
More informationEvolving Realities of HIV Treatment in Resource-limited Settings
Evolving Realities of HIV Treatment in Resource-limited Settings Papa Salif Sow MD, MSc Department of Infectious Diseases University of Dakar, Senegal Introduction: ARV access in RLS Scale-up of ART has
More informationPharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority?
Pharmacovigilance in HIV/AIDS Public Health Programmes: Luxury or Priority? Micheline Diepart WHO HIV/AIDS ATC Launching a Three-Year Initiative Developing pharmacovigilance (PV) for antiretroviral medicines
More informationREVIEW OF TUBERCULOSIS EPIDEMIOLOGY
Part I REVIEW OF TUBERCULOSIS EPIDEMIOLOGY 1. 2. 3. Estimated Tuberculosis Burden 7 Tuberculosis Case Notification 10 Prevalence and Tuberculin Surveys 22 PART 1 5 TABLE 1: Latest notification of tuberculosis
More informationIntegrating palliative care and end of life care into TB/MDR-TB programmes
Integrating palliative care and end of life care into TB/MDR-TB programmes Robert Makombe 26 th October 2916 47 th Global Annual Lung Health Conference Liverpool Definition of Palliative Care An approach
More informationLatest Funding Trends in AIDS Response
Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July
More informationLessons learned from the IeDEA West Africa Collaboration
Lessons learned from the IeDEA West Africa Collaboration François DABIS with the contribution of Didier Koumavi EKOUEVI INSERM U-897, Bordeaux, France, Programme PACCI, ANRS site, Abidjan, Côte d Ivoire
More informationThe United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America
The United Nations flag outside the Secretariat building of the United Nations, New York City, United States of America Mike Segar / Reuters Executive Summary Context On 26 September 2018, the United Nations
More informationEpidemiology of chronic diseases in developing countries. Prof Isaac Quaye, UNAM SOM
Epidemiology of chronic diseases in developing countries Prof Isaac Quaye, UNAM SOM Synopsis Definitions: epidemiology/chronic disease Changing trends in disease epidemiology towards non communicable Core
More informationTHE Price of a Pandemic 2017
THE Price of a Pandemic 2017 From 2000-2015: 33 million people died because of TB at a global economic cost of $617bn This report was produced the Global TB Caucus, an international network of over 2,000
More informationCombating NCDs Challenge and the Evolving Responses in India
Combating NCDs Challenge and the Evolving Responses in India Dr Sudhir Gupta Addl. Dy. Director General Ministry of Health & Family Welfare 2 nd November 2012 1 Contents of presentation NCDs as a public
More informationRisk Monitor How-to guide
Risk Monitor How-to guide Contents INTRODUCTION... 3 RESEARCH METHODS... 4 THE RISK MONITOR... 5 STEP-BY-STEP GUIDE... 6 Definitions... 7 PHASE ONE STUDY PLANNING... 8 Define the target population... 8
More informationScaling up priority HIV/AIDS interventions in the health sector
TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June
More informationProgress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium
More informationthe African scenario
the African scenario The burden of non-communicable diseases in Africa is already proportionately greater than that in Western countries The diabetes care delivery agenda in Africa is dominated by poverty,
More informationNon-communicable disease prevention and management in health financing: What can be done at policy level? A desk review
Non-communicable disease prevention and management in health financing: What can be done at policy level? A desk review Introduction Zimbabwe has a high burden of disease to which all the six building
More informationPaediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance
Paediatric TB: disease burden estimation and the opportunities it creates to strengthening surveillance Workshop 04 44 th Union World Conference on Lung Health Paris, 31 October, 2013 GLOBAL TB PROGRAMME
More informationS05-1 Social-economic impact of diabetes in New Zealand
S05-1 Social-economic impact of diabetes in New Zealand Steve Crew 1 1 Chief Executive, Diabetes New Zealand, Wellington, New Zealand As in many other developed countries, diabetes is one of New Zealand
More informationFinding the missing TB cases
Finding the missing TB cases Optimizing strategies to enhance case detection in high HIV burden settings Dr Malgosia Grzemska Global TB Programme, WHO/HQ, Geneva SWITZERLAND Child and Adolescent TB Working
More informationThe Drivers of Non- Communicable Diseases
The Drivers of Non- Communicable Diseases Susan B. Shurin, MD NCI Center for Global Health Consortium of Universities for Global Health, Boston MA 27 March 2015 Declaration of Interests For the past decade,
More informationLatest developments in WHO estimates of TB disease burden
Latest developments in WHO estimates of TB disease burden WHO Global Task Force on TB Impact Measurement meeting Glion, 1-4 May 2018 Philippe Glaziou, Katherine Floyd 1 Contents Introduction 3 1. Recommendations
More informationINTERNAL QUESTIONS AND ANSWERS DRAFT
WHO CONSOLIDATED GUIDELINES ON THE USE OF ANTIRETROVIRAL DRUGS FOR TREATING AND PREVENTING HIV INFECTION Background: INTERNAL QUESTIONS AND ANSWERS DRAFT At the end of 2012, 9.7 million people were receiving
More informationGlobal health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
More informationAnna Maria Geretti on behalf of co-authors Professor of Virology & Infectious Diseases, University of Liverpool Expert Scientist, Roche Pharma
Anna Maria Geretti on behalf of co-authors Professor of Virology & Infectious Diseases, University of Liverpool Expert Scientist, Roche Pharma Research & Early Discovery Funding: Wellcome Trust, National
More informationThe Global Impact of Dementia
The Global Impact of Dementia Martin Prince No conflicts of interest Centre for Global Mental Health Health Service and Population Research Department King s College London 1066drg@iop.kcl.ac.uk Agenda
More informationART for prevention the task ahead
ART for prevention the task ahead Dr Teguest Guerma WHO/HQS WHO's role and vision Status of the epidemic Overview Progress and challenges in treatment and prevention scale up ART for prevention Questions
More informationTB Intensive San Antonio, Texas December 1-3, 2010
TB Intensive San Antonio, Texas December 1-3, 2010 TB & Diabetes Barbara Seaworth, MD; HNTC December 3, 2010 Dual Epidemic Diabetes - Tuberculosis Barbara J. Seaworth MD Medical Director, Heartland NTBC
More informationDownloaded from:
Maher, D; Sekajugo, J; Harries, AD; Grosskurth, H (2010) Research needs for an improved primary care response to chronic non-communicable diseases in Africa. Tropical medicine international health, 15
More informationIHI Biomedical Sciences Group. Joseph Mugasa, PhD, PD. Stakeholders Meeting
IHI Biomedical Sciences Group Joseph Mugasa, PhD, PD Stakeholders Meeting Jan 2013 Overview Biomedical group carries out a range of laboratory studies with the aim of understanding the pathogenesis, diagnosis
More informationTB EPIDEMIOLOGY: IMPACT ON CHILDREN. Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University
TB EPIDEMIOLOGY: IMPACT ON CHILDREN Anneke C. Hesseling Desmond Tutu TB Centre Department Paediatrics and Child Health Stellenbosch University Robert Koch 1843-1910 Discovered M. tuberculosis 1882 TB deaths
More informationD:A:D Study Teaching Material
D:A:D Study Teaching Material Data Collection of Adverse events of anti-hiv Drugs (D:A:D) study December 2012 - CHIP Background The D:A:D Study, is a prospective cohort study (collaboration) initiated
More informationTuberculosis-HIV epidemic situation and emerging challenges in North India
NTI Bulletin 2015,51 /1&4, 1 7 Tuberculosis-HIV epidemic situation and emerging challenges in North India Rajesh Deshmukh 1,3, Raghu Ram Rao 2, Shah A 2,3, Sreenivas A Nair 3, R S Gupta 1, SD Khaparde
More informationResponse to HIV LOGISTICAL AND OTHER PERSPECTIVES
Response to HIV LOGISTICAL AND OTHER PERSPECTIVES Margaret Brandeau Department of Management Science and Engineering Department of Medicine Stanford University Topics HIV: A humanitarian crisis Planning
More informationCardiovascular Topics
5 CARDIOVASCULAR JOURNAL OF AFRICA Vol, No 3, April 13 AFRICA Cardiovascular Topics The prevalence and distribution of non-communicable diseases and their risk factors in Kasese district, Uganda CHARLES
More informationHealth Literacy for NCD prevention, management and prompting equality
Health Literacy for NCD prevention, management and prompting equality How to use health literacy to improve understanding and responses to NCDs? WHO Global Coordination Mechanism on NCDs Working Group
More informationNumber of people receiving ARV therapy in developing and transitional countries by region,
Progress in numbers The last six months have seen dramatic progress toward the 3 by 5 target. Between June and, the number of people receiving antiretroviral (ARV) therapy in developing and transitional
More informationEpidemiology of Diabetes Mellitus in Asia
Epidemiology of Diabetes Mellitus in Asia Nam H. Cho Professor of Preventive Medicine Director of Clinical Epidemiology Ajou University School of Medicine and Hospital, Suwon Korea President-elect of International
More informationPlace matters: why cities are key to ending AIDS
Place matters: why cities are key to ending AIDS Cities for Social Transformation Towards Ending AIDS 20 th International AIDS Conference Melbourne, Australia 19 July 2014 Steven J. Kraus Director UNAIDS
More informationTB Intensive San Antonio, Texas November 11 14, 2014
TB Intensive San Antonio, Texas November 11 14, 2014 TB and Diabetes Barbara Seaworth, MD November 13, 2014 Barbara Seaworth, MD has the following disclosures to make: No conflict of interests No relevant
More information